Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry

Pigment Cell and Melanoma Research

Volumn 27, Issue 3, 2014, Pages 442-453

  Stanisz, Hedwig ^a   Saul, Stephanie ^a   Müller, Cornelia S L ^a   Kappl, Reinhard ^a   Niemeyer, Barbara A ^a   Vogt, Thomas ^a   Hoth, Markus ^a   Roesch, Alexander ^a,b   Bogeski, Ivan ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Calcium; Invasion; Melanoma; Migration; Orai1; Proliferation; STIM2

Indexed keywords

CALCIUM; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; STROMAL INTERACTION MOLECULE 2; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CELL ADHESION MOLECULE; CULTURE MEDIUM; HISTONE DEMETHYLASE; HOMEODOMAIN PROTEIN; KDM5B PROTEIN, HUMAN; MELANIN; NUCLEAR PROTEIN; ORAI1 PROTEIN, HUMAN; REPRESSOR PROTEIN; SMALL INTERFERING RNA; STIM2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR BRN-2; TRANSCRIPTION FACTOR POU; TUMOR PROTEIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; GENE SILENCING; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MELANOGENESIS; MELANOMA; MELANOMA CELL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BOVINAE; BRAIN TUMOR; CALCIUM SIGNALING; CELL DIVISION; CELL MOTION; CULTURE MEDIUM; DRUG EFFECTS; EXTRACELLULAR FLUID; GENETICS; GLYCOSYLATION; ION TRANSPORT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHARMACOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; RNA INTERFERENCE; SECONDARY; SERUM; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; BRAIN NEOPLASMS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM SIGNALING; CATTLE; CELL ADHESION MOLECULES; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CULTURE MEDIA; EXTRACELLULAR FLUID; GLYCOSYLATION; HOMEODOMAIN PROTEINS; HUMANS; ION TRANSPORT; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; LYMPHATIC METASTASIS; MELANINS; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POU DOMAIN FACTORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SERUM;

EID: 84898925257     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12222     Document Type: Article

References (63)

1. Balch, C.M., Gershenwald, J.E., Soong, S.-J. et al. (2009). Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 27, 6199-6206.
2. 2+ entry in neurons and plays a key role in hypoxic neuronal cell death. Sci. Signal. 2, ra67.
3. Bogeski, I., Kummerow, C., Al-Ansary, D. et al. (2010). Differential redox regulation of ORAI ion channels: a mechanism to tune cellular calcium signaling. Sci. Signal. 3, ra24.
4. 2+ levels. Cell 131, 1327-1339.
5. Chen, Y.-F., Chiu, W.-T., Chen, Y.-T., Lin, P.-Y., Huang, H.-J., Chou, C.-Y., Chang, H.-C., Tang, M.-J., and Shen, M.-R. (2011). Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc. Natl Acad. Sci. 108, 15225-15230.
6. Clapham, D.E. (2007). Calcium signaling. Cell 131, 1047-1058.
7. Devi, S., Kedlaya, R., Maddodi, N., Bhat, K.M., Weber, C.S., Valdivia, H., and Setaluri, V. (2009). Calcium homeostasis in human melanocytes: role of transient receptor potential melastatin 1 (TRPM1) and its regulation by ultraviolet light. Am. J. Physiol. Cell Physiol. 297, C679-C687.
8. Duncan, L.M., Deeds, J., Cronin, F.E., Donovan, M., Sober, A.J., Kauffman, M., and McCarthy, J.J. (2001). Melastatin expression and prognosis in cutaneous malignant melanoma. J. Clin. Oncol. 19, 568-576.
9. Elias, P.M., Ahn, S.K., Brown, B.E., Crumrine, D., and Feingold, K.R. (2002). Origin of the epidermal calcium gradient: regulation by barrier status and role of active vs passive mechanisms. J. Invest. Dermatol. 119, 1269-1274.
10. Feske, S., Gwack, Y., Prakriya, M., Srikanth, S., Puppel, S.H., Tanasa, B., Hogan, P.G., Lewis, R.S., Daly, M., and Rao, A. (2006). A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179-185.
11. Flourakis, M., Lehen'kyi, V., Beck, B. et al. (2010). Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells. Cell Death Dis. 1, e75.
12. Garbe, C., Eigentler, T.K., Keilholz, U., Hauschild, A., and Kirkwood, J.M. (2011). Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist 16, 5-24.
13. Garraway, L.A., Widlund, H.R., Rubin, M.A. et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117-122.
14. Goodall, J., Carreira, S., Denat, L., Kobi, D., Davidson, I., Nuciforo, P., Sturm, R.A., Larue, L., and Goding, C.R. (2008). Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Cancer Res. 68, 7788-7794.
15. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
16. Gwack, Y., Srikanth, S., Feske, S., Cruz-Guilloty, F., Oh-Hora, M., Neems, D.S., Hogan, P.G., and Rao, A. (2007). Biochemical and functional characterization of orai proteins. J. Biol. Chem. 282, 16232-16243.
17. Hennings, H., Michael, D., Cheng, C., Steinert, P., Holbrook, K., and Yuspa, S.H. (1980). Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19, 245-254.
18. Hoek, K.S., and Goding, C.R. (2010). Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 23, 746-759.
19. Hoek, K.S., Schlegel, N.C., Brafford, P. et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290-302.
20. Hoek, K.S., Eichhoff, O.M., Schlegel, N.C., Döbbeling, U., Kobert, N., Schaerer, L., Hemmi, S., and Dummer, R. (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650-656.
21. Hogan, P.G., Lewis, R.S., and Rao, A. (2010). Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol 28, 491-533.
22. Hou, M.-F., Kuo, H.-C., Li, J.-H., Wang, Y.-S., Chang, C.-C., Chen, K.-C., Chen, W.-C., Chiu, C.-C., Yang, S., and Chang, W.-C. (2011). Orai1/CRACM1 overexpression suppresses cell proliferation via attenuation of the store-operated calcium influx-mediated signalling pathway in A549 lung cancer cells. Biochim. Biophys. Acta - General Subjects 1810, 1278-1284.
23. Imokawa, G., Kobayasi, T., and Miyagishi, M. (2000). Intracellular signaling mechanisms leading to synergistic effects of endothelin-1 and stem cell factor on proliferation of cultured human melanocytes. Cross-talk via trans-activation of the tyrosine kinase c-kit receptor. J. Biol. Chem. 275, 33321-33328.
24. 2+ oscillations and gene expression. Proc. Natl Acad. Sci. 109, 6969-6974.
25. 2+ channel Orai1. J. Biol. Chem. 288, 1653-1664.
26. Levy, C., Khaled, M., and Fisher, D.E. (2006). MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12, 406-414.
27. 2+ influx. Curr. Biol. 15, 1235-1241.
28. Lu, S., Slominski, A., Yang, S.-E., Sheehan, C., Ross, J., and Carlson, J.A. (2010). The correlation of TRPM1 (melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi. J. Cutan. Pathol. 37, 26-40.
29. Mancarella, S., Potireddy, S., Wang, Y. et al. (2013). Targeted STIM deletion impairs calcium homeostasis, NFAT activation, and growth of smooth muscle. FASEB J. 27, 893-906.
30. McAndrew, D., Grice, D.M., Peters, A.A. et al. (2011). ORAI1-mediated calcium influx in lactation and in breast cancer. Mol. Cancer Ther. 10, 448-460.
31. McGill, G.G., Horstmann, M., Widlund, H.R. et al. (2002). Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707-718.
32. 2+ transport. Nat. Rev. Cancer 7, 519-530.
33. Motiani, R.K., Abdullaev, I.F., and Trebak, M. (2010). A novel native store-operated calcium channel encoded by Orai3. J. Biol. Chem. 285, 19173-19183.
34. Oancea, E., Vriens, J., Brauchi, S., Jun, J., Splawski, I., and Clapham, D.E. (2009). TRPM1 forms ion channels associated with melanin content in melanocytes. Sci. Signal. 2, ra21.
35. Parekh, A.B., and Putney, J.W. Jr (2005). Store-operated calcium channels. Physiol. Rev. 85, 757-810.
36. Parvez, S., Beck, A., Peinelt, C., Soboloff, J., Lis, A., Monteilh-Zoller, M., Gill, D.L., Fleig, A., and Penner, R. (2008). STIM2 protein mediates distinct store-dependent and store-independent modes of CRAC channel activation. FASEB J. 22, 752-761.
37. Peel, S., Liu, B., and Hall, I. (2006). A key role for STIM1 in store operated calcium channel activation in airway smooth muscle. Respir. Res. 7, 119.
38. Pinner, S., Jordan, P., Sharrock, K., Bazley, L., Collinson, L., Marais, R., Bonvin, E., Goding, C., and Sahai, E. (2009). Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res. 69, 7969-7977.
39. Pinnix, C.C., Lee, J.T., Liu, Z.-J. et al. (2009). Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Res. 69, 5312-5320.
40. Potier, M., Gonzalez, J.C., Motiani, R.K., Abdullaev, I.F., Bisaillon, J.M., Singer, H.A., and Trebak, M. (2009). Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J. 23, 2425-2437.
41. Prevarskaya, N., Skryma, R., and Shuba, Y. (2011). Calcium in tumour metastasis: new roles for known actors. Nat. Rev. Cancer 11, 609-618.
42. Qu, B., Al-Ansary, D., Kummerow, C., Hoth, M., and Schwarz, E.C. (2011). ORAI-mediated calcium influx in T cell proliferation, apoptosis and tolerance. Cell Calcium 50, 261-269.
43. 2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 8, 361-375.
44. Roesch, A., Fukunaga-Kalabis, M., Schmidt, E.C., Zabierowski, S.E., Brafford, P.A., Vultur, A., Basu, D., Gimotty, P., Vogt, T., and Herlyn, M. (2010). A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583-594.
45. Roesch, A., Vultur, A., Bogeski, I. et al. (2013). Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1Bhigh cells. Cancer Cell 23, 811-825.
46. Ruano, Y., Mollejo, M., Ribalta, T., Fiano, C., Camacho, F., Gomez, E., De Lope, A., Hernandez-Moneo, J.-L., Martinez, P., and Melendez, B. (2006). Identification of novel candidate target genes in amplicons of glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol. Cancer 5, 39.
47. Saito, H., Yasumoto, K., Takeda, K., Takahashi, K., Fukuzaki, A., Orikasa, S., and Shibahara, S. (2002). Melanocyte-specific microphthalmia-associated transcription factor isoform activates its own gene promoter through physical interaction with lymphoid-enhancing factor 1. J. Biol. Chem. 277, 28787-28794.
48. Salti, G.I., Manougian, T., Farolan, M., Shilkaitis, A., Majumdar, D., and Das Gupta, T.K. (2000). Microphthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. Cancer Res. 60, 5012-5016.
49. Sato-Jin, K., Nishimura, E.K., Akasaka, E. et al. (2008). Epistatic connections between microphthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders. FASEB J. 22, 1155-1168.
50. Satyamoorthy, K., Dejesus, E., Linnenbach, A.J., Kraj, B., Kornreich, D.L., Rendle, S., Elder, D.E., and Herlyn, M. (1997). Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 7(Suppl 2), S35-S42.
51. Slominski, A., Wortsman, J., Luger, T., Paus, R., and Solomon, S. (2000). Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80, 979-1020.
52. Slominski, A., Zbytek, B., Pisarchik, A., Slominski, R.M., Zmijewski, M.A., and Wortsman, J. (2006). CRH functions as a growth factor/cytokine in the skin. J. Cell. Physiol. 206, 780-791.
53. Smalley, K.S., Haass, N.K., Brafford, P.A., Lioni, M., Flaherty, K.T., and Herlyn, M. (2006). Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Mol. Cancer Ther. 5, 1136-1144.
54. Soboloff, J., Rothberg, B.S., Madesh, M., and Gill, D.L. (2012). STIM proteins: dynamic calcium signal transducers. Nat. Rev. Mol. Cell Biol. 13, 549-565.
55. Stanisz, H., Stark, A., Kilch, T., Schwarz, E.C., Muller, C.S., Peinelt, C., Hoth, M., Niemeyer, B.A., Vogt, T., and Bogeski, I. (2012). ORAI1 Ca(2+) channels control endothelin-1-induced mitogenesis and melanogenesis in primary human melanocytes. J. Invest. Dermatol. 132, 1443-1451.
56. Thurber, A.E., Douglas, G., Sturm, E.C., Zabierowski, S.E., Smit, D.J., Ramakrishnan, S.N., Hacker, E., Leonard, J.H., Herlyn, M., and Sturm, R.A. (2011). Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Oncogene 30, 3036-3048.
57. Tsutsumi, M., Denda, S., Inoue, K., Ikeyama, K., and Denda, M. (2008). Calcium ion gradients and dynamics in cultured skin slices of rat hindpaw in response to stimulation with ATP. J. Invest. Dermatol. 129, 584-589.
58. 2+ entry. Science 312, 1220-1223.
59. Yang, S., Zhang, J.J., and Huang, X.-Y. (2009). Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15, 124-134.
60. Zbytek, B., Wortsman, J., and Slominski, A. (2006). Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol. Endocrinol. 20, 2539-2547.
61. 2+ store to the plasma membrane. Nature 437, 902-905.
62. Zhang, S.L., Yeromin, A.V., Zhang, X.H., Yu, Y., Safrina, O., Penna, A., Roos, J., Stauderman, K.A., and Cahalan, M.D. (2006). Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc. Natl Acad. Sci. USA 103, 9357-9362.
63. 2+ sensory region of STIM1 and STIM2. Biochem. Biophys. Res. Commun. 369, 240-246.